AASLD: Cirrhosis Patients Benefit from Anticoagulant (CME/CE)
(MedPage Today) — SAN FRANCISCO -– In people with advanced cirrhosis, a low molecular weight heparin can prevent portal vein thrombosis, a researcher said here.
(MedPage Today) — SAN FRANCISCO -– In people with advanced cirrhosis, a low molecular weight heparin can prevent portal vein thrombosis, a researcher said here.
Comments are closed.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information: verify here.